Diabetes Insights - Breakthroughs and Innovators

In this episode of Diabetes Insights, we’re talking about a topic that doesn’t get nearly enough attention in diabetes care: Sexual Health. Studies show that people with diabetes are twice as likely to experience sexual dysfunction, yet many patients and healthcare professionals struggle to discuss it openly. Join host Vivienne Parry as she speaks with Dr. Aleksandra Uruska, a diabetologist from P...

Could weight loss be the key to managing heart failure? In this episode of Diabetes Insights, we dive into the STEP-HFpEF trial, a groundbreaking study exploring the role of GLP-1 receptor agonists in heart failure with preserved ejection fraction (HFpEF). Host Vivienne Parry speaks with Prof. Melanie Davies (University of Leicester), Prof. Mark Petrie (University of Glasgow), and Prof. Mikhail Ko...

In this episode of Diabetes Insights, we explore the power of screening in type 1 diabetes and the potential for early intervention. Host Vivienne Parry speaks with EASD President, Prof. Chantal Mathieu and Prof. Annette Ziegler about groundbreaking research into detecting type 1 diabetes in its earliest stages. With new disease-modifying therapies on the horizon, early screening is no longer just...

In this episode, we dive into the critical role of the European Diabetes Forum (EUDF) in shaping diabetes policy across Europe. Host Vivienne Parry speaks with Bart Torbeyns about why bringing together stakeholders - including patient associations, research institutions, healthcare professionals, and industry - is essential to influencing policy makers and improving access to diabetes care. We dis...

In this episode of Diabetes Insights, we dive into the latest findings from the FLOW Trial - a groundbreaking trial evaluating the impact of GLP-1 receptor agonists on chronic kidney disease (CKD). This discussion features expert insights from Dr. Peter Rossing, Dr. Richard Pratley and Dr. Katherine Tuttle. The results reveal a 24% reduction in kidney disease progression, an 18% decrease in major...

In this episode of the EASDtv Podcast, we explore a cutting-edge approach to diabetes screening - using voice. Dr Guy Fagherazzi and Dr Abir Elbeji from the Luxembourg Institute of Health discuss their research into how AI-powered voice analysis can detect subtle vocal changes linked to type 2 diabetes. With a growing global burden of undiagnosed diabetes, this technology could provide a scalable,...

In this episode, we sit down with Prof. Juleen Zierath, recipient of the 2024 EASD-Novo Nordisk Foundation Diabetes Prize for Excellence. A former EASD President, Prof. Zierath shares insights from her pioneering research on the role of exercise in diabetes management, exploring how physical activity can improve glucose metabolism, insulin sensitivity, and overall metabolic health. She also discus...

The role of beta cells in diabetes is well established, but how important are the other cells within the islet network? In this episode of Diabetes Insights, Prof. Mark Huising (University of California) and Prof. Guy Rutter (Imperial College London) dive into the intricate crosstalk between islet cells and its impact on insulin secretion and glucose regulation. They debate the influence of alpha...

In this episode, Prof. Hindrik Mulder, Editor-in-Chief of Diabetologia, joins us to discuss the journals accomplishments over the past year and its vision for the future of diabetes research. From embracing AI in research processes to addressing global health disparities, Prof. Mulder highlights how Diabetologia remains at the forefront of the field. He also shares his excitement about advancement...

In this episode, Prof. Frank Tacke (Charité – Universitätsmedizin Berlin), Prof. Michael Roden (University of Düsseldorf), and Prof. Hannele Yki-Järvinen (University of Helsinki) discuss the groundbreaking new guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD). The episode explores the shift from the term "NASH" to MASLD, addressing the rationale behind this change and...

In this episode, we explore the vital role of National and European diabetes forums, respectively, in shaping policies and improving care for people living with diabetes. Featuring Bogdan Timor (Romanian Diabetes Forum) and Frank Nobels (Belgian Diabetes Forum), the discussion highlights how collaborative efforts, and shared strategies can drive early detection, prevention, and better management o...

In this episode, Aoife Egan and Daniel Morganstein discuss the complexities of managing glycaemic emergencies in special patient populations. From diabetic ketoacidosis (DKA) during pregnancy to hypoglycaemic crises triggered by cancer treatments, they explore the importance of multidisciplinary collaboration, education, and awareness in delivering timely and effective care.

QWINT: A Paradigm Shift in Insulin Therapy In this episode, Harpreet Bajaj, Carol Wysham, and Richard Bergenstal explore the revolutionary QWINT program, a once-weekly insulin therapy currently in development. With a unique mechanism of action resulting in a 17-day half-life, QWINT has the potential to transform diabetes care by reducing the treatment burden for patients and caregivers alike. The...

In this first episode of the year, our very own president Prof. Chantal Mathieu and other leading experts explore the future of type 1 diabetes. Join Vivienne Parry as she sits down with renowned experts - EASD President Prof. Chantal Mathieu, Dr. Peter Rossing, and Dr. Rory McCrimmon - to discuss the future of type 1 diabetes. From global screening initiatives to cutting-edge research on islet tr...

In this episode, Dr Elisa De Franco, recipient of the 2024 EASD Minkowski Award, takes us on a journey through her groundbreaking research into neonatal diabetes. Dr De Franco’s work has revolutionised the understanding and treatment of this rare form of diabetes, diagnosed in babies under six months old. From identifying 10 - 15 genetic mutations linked to neonatal diabetes to shedding light on b...

Adipose tissue isn't just "fat" - it's a remarkable endocrine organ with transformative impacts on health and diabetes. In this episode, discover groundbreaking insights from Dr Alice Williamson of Queen Mary University, London, and Dr Lori Goodyear of Harvard Medical School. Learn about the genetic factors behind insulin resistance and the revolutionary role of exercise in remodelling adipose tis...

In this episode, Alice Rickford and Andrzej Kokoszka discuss the complex challenges of managing diabetes in disadvantaged communities and among individuals with mental health conditions. Alice Rickford, a healthcare professional from London, highlights barriers like homelessness, access to care, and the stigma faced by people living with diabetes in vulnerable situations. Andrzej Kokoszka, from Po...

In Episode 3 of our podcast, experts from Argentina, Mexico, Pakistan, and Sri Lanka share a comprehensive view of the diabetes epidemic in their countries. The conversation highlights the alarming rise in diabetes and pre-diabetes cases, touching on the challenges faced by their healthcare systems and the urgent need for government intervention. Dr. Prasad Katulanda (Sri Lanka) discusses the expo...

Episode 2 features Matthias Blüher and Anette Ziegler, two leading experts in diabetes research, as they share their insights into the future of diabetes care by 2030. The conversation explores innovative developments in the prevention and treatment of both Type 1 and Type 2 diabetes, with a focus on early diagnosis, immune interventions, and the potential of incretin-based therapies. Dr. Blüher d...

Our first episode features Dr. Roy Taylor, a leading diabetes researcher and recipient of the prestigious EASD Claude Bernard Prize, discussing groundbreaking insights into type 2 diabetes remission. He shares his journey in proving that type 2 diabetes can, in many cases, be reversed through targeted weight loss to reduce fat in the liver and pancreas. Dr. Taylor recounts the challenges he faced...